Alberto Briganti is Associate Professor of Urology at Università Vita-Salute San Raffaele, Milan, Italy and he is the deputy director of the Urological Research Institute (URI) of IRCCS Ospedale San Raffaele, Milan, Italy. He earned his MD in 2002 at Università Vita-Salute San Raffaele where he also pursued residency. He completed a uro-oncological fellowship at the Cancer Prognostics and Health Outcomes Unit, University of Montreal in 2006. In 2016 he obtained his PhD in Clinical and Experimental Biotechnology in Urology at Magna Graecia University, Italy.
He is a member of the Scientific Congress Office of the EAU and a member of the EAU Guidelines Office Board. He is also a member of the Scientific Committee of the Italian Association of Urology (SIU) as well as the European Multidisciplinary Meeting on Urological Cancer (EMUC). He is a fellow of the European Board of Urology (EBU) and a Faculty member of the European School of Urology (ESU). He is the 2016 EAU Crystal Matula Award winner and has published over 450 peer-reviewed publications. His main areas of interest are urological oncology with a specific focus on prostate cancer and treatment related sexual dysfunctions.
Dr Briganti is supported by: